Clinical trial sponsors, pharmaceutical and biotech companies, have an ethical and regulatory obligation to ensure that patients receive continued, post-trial access to treatments that have been identified as beneficial during a trial.
This webinar will introduce the traditional route many sponsors take when looking to uphold ethical obligations and continue post-trial treatment access, along with the unnecessary cost and complexity present in many scenarios.
After examining traditional approaches and their often incompatibility with optimised and cost-effective operations, Almac’s subject matter expert(s) will present the highly effective, yet under-utilised alternative: Managed Access Programmes underpinned by patient-centric, on-demand supply strategy.
Join us on Thursday 21 September at 3pm BST to discover how MAPs and Just in Time Manufacturing combined can empower you to better serve patients and meet ethical obligations, free up resource, optimise operations and maximise ROI. There will also be a live Q&A at the conclusion of the presentation.
Key Learning Objectives
- Gain an overview of both services - take a deep dive into the key features of Almac’s MAPs and JTM service solutions
- Unlock the benefits of operating MAPs – learn why using a tailored solution such as JTM is the key to success
- Optimise your supply chain - discover how to maximise efficiency for your MAP utilising advanced supply chain techniques
- Avoid the pitfalls of post-trial treatment provision – understand how to minimise risks to ensure a streamlined delivery for your MAP
